Hims & Hers Health HIMS
NYSE HIMS
$31.84 +0.75 (+2.41%)
As of: Aug 20, 2026 · 3:59 PM EDT

Hims & Hers Health (HIMS) Change in Account Payables (2019 - 2026)

Hims & Hers Health (HIMS) posted Change in Account Payables of $167.6 million for Q1 2026, up 466.02% sequentially from -$45.8 million in Q4 2025, and up 1058.32% YoY from $14.5 million in Q1 2025.

Hims & Hers Health (HIMS) Change in Account Payables (2019 - 2026) Analysis & Trends

Hims & Hers Health has reported Change in Account Payables for 8 years, with the latest figure at $167.6 million in Q1 2026.

  • Quarterly Change in Account Payables rose 1058.32% year-over-year to $167.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $183.5 million (up 236.14% YoY) and the FY2025 annual result came in at $30.3 million, down 30.69% from the prior year.
  • Change in Account Payables grew to $167.6 million in Q1 2026 per HIMS's latest filing, from -$45.8 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $167.6 million in Q1 2026 and troughed at -$45.8 million in Q4 2025.
  • A 5-year average of $15.4 million and a median of $4.0 million in 2023 frame the typical range for Change in Account Payables.
  • The sharpest annual moves came in 2024 and 2025: Change in Account Payables soared 1922.18% in 2024, then sank 629.0% in 2025.
  • Over 5 years, Change in Account Payables stood at -$609000.0 in 2022, then jumped by 579.97% to $2.9 million in 2023, then soared by 196.2% to $8.7 million in 2024, then tumbled by 629.0% to -$45.8 million in 2025, then surged by 466.02% to $167.6 million in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods registered $167.6 million, -$45.8 million, and $71.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -53.00 Mn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -143.74 Mn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -21.20 Mn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Hims & Hers Health 7.42 Bn 6.57 Bn 480.80 Mn 156.15 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 156.15 Mn
Jun 30, 2026 156.15 Mn
Mar 31, 2026 167.64 Mn
Mar 31, 2026 167.64 Mn
Dec 31, 2025 -45.80 Mn
Dec 31, 2025 -45.80 Mn
Sep 30, 2025 70.95 Mn
Sep 30, 2025 70.95 Mn
Jun 30, 2025 -9.33 Mn
Jun 30, 2025 -9.33 Mn
Mar 31, 2025 14.47 Mn
Mar 31, 2025 14.47 Mn
Dec 31, 2024 8.66 Mn
Dec 31, 2024 8.66 Mn
Sep 30, 2024 18.90 Mn
Sep 30, 2024 18.90 Mn
Jun 30, 2024 12.55 Mn
Jun 30, 2024 12.55 Mn
Mar 31, 2024 3.60 Mn
Mar 31, 2024 3.60 Mn